Publications of Sascha Young Kupke
All genres
Talk (26)
2019
Talk
A novel type of defective interfering particle for antiviral therapy. 26th ESACT Meeting, Copenhagen, Denmark (2019)
Talk
Multiscale model of DIP interference and production during influenza A virus infection in animal cell culture. 4th Workshop on Virus Dynamics, Paris, France (2019)
2018
Talk
Single-Cell analysis uncover a novel influenza A virus-derived defective interfering particle for antiviral therapy. Vaccine Technology VII, Mont Tremblant, Canada (2018)
2017
Talk
Multiscale model of influenza virus infection predicts viral release dynamics in cell cultures for a wide range of infection conditions. 3rd Workshop on Virus Dynamics, Heidelberg, Germany (2017)
2016
Talk
Single-Cell Analysis of Influenza A Virus-Infected Cells. 26th Annual Meeting of the Society for Virology, Münster, Germany (2016)
Talk
Heterogeneity in Influenza A Virus Infection Unveiled by Single-Cell Analysis and Stochastic Mathemeatical Modeling. Single Cell Technologies 2016, Frankfurt/Main (2016)
Talk
Single-Cell Analysis of Influenza A Virus-Infected Cells for the Optimization of Cell Culture-Based Vaccine Production. Vaccine Technology VI, Albufeira, Portugal (2016)
Poster (27)
2024
Poster
Defective Interfering Particles of Influenza A Virus As Broad-Spectrum Antivirals. 33rd Annual Meeting of the Society for Virology (GfV), Vienna (Austria) (2024)
Poster
Mechanisms of antiviral action of the influenza defective interfering particle “OP7”. 33rd Annual Meeting of the Society for Virology (GfV), Vienna (Austria) (2024)
2023
Poster
Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccination. 32nd Annual Meeting of the Society for Virology (GfV), Ulm (Germany) (2023)
Poster
Genetically engineered defective interfering particles of influenza A virus for antiviral treatment and vaccination. 8th European Congress of Virology, Gdańsk (Poland) (2023)
Poster
Absolute quantification of viral proteins during single-round replication of vaccine producer cell lines. 32nd Annual Meeting of the Society for Virology (GfV) , Ulm (Germany) (2023)
Poster
Absolute quantification of influenza A virus proteins during single-round replication in vaccine producer cell lines. 16th PEACe (Protein Expression in Animal Cells) Conference, Sitges (Spain) (2023)
Poster
Influenza A virus OP7 defective interfering particles: Cell culture-based production and antiviral efficacy in vivo. Cell Culture Engineering (CCE) XVIII , Cancun (Mexico) (2023)
Poster
A Scalable High-Yield Process for Production of Influenza A Virus Defective Interfering Particles and In Vivo Studies. Himmelfahrtstagung on Bioprocess Engineering 2023, Weimar (Germany) (2023)
Poster
Influenza A Virus Chimeric OP7 Defective Interfering Particles: Cell Culture-based Production and In Vivo Antiviral Efficacy. 32nd Annual Meeting of the Society for Virology (GFV), Ulm (Germany) (2023)
Poster
Reduced transcription of the mutated genomic segment 7 of the novel “OP7” influenza defective interfering particle intended for use as an antiviral. 8th European Congress of Virology, Gdańsk (Poland) (2023)
Poster
Promoter mutations in novel “OP7” influenza defective interfering particle severely reduce transcription of its genomic segment 7. 32nd Annual Meeting of the Society for Virology (GfV), Ulm (Germany) (2023)
Poster
Promoter mutations in the novel “OP7” influenza defective interfering particle intended for use as antiviral. 17th Vaccine Congress, Glasgow (Scotland) (2023)
2022
Poster
Reverse genetics for Influenza A virus to generate genetically engineered defective interfering particles for antiviral treatment and vaccination. 27th ESACT Meeting, Lisbon (Portugal) (2022)